Danske Bank’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,464
Closed -$874K 1637
2025
Q3
$874K Sell
25,464
-10,044
-28% -$288K ﹤0.01% 704
2025
Q2
$960K Sell
35,508
-7,894
-18% -$229K ﹤0.01% 718
2025
Q1
$1.29M Buy
43,402
+10,643
+32% +$406K ﹤0.01% 788
2024
Q4
$1.3M Buy
32,759
+6,080
+23% +$230K ﹤0.01% 817
2024
Q3
$908K Buy
+26,679
New +$751K ﹤0.01% 826

Other funds holding VCYT

Danske Bank's VCYT Position: Q4 2025 in Review

Danske Bank sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 25,464 shares — an estimated $874K sold.

Danske Bank first reported a position in VCYT in Q3 2024 and held it in 5 quarters. The position peaked at $1.3M in Q4 2024. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Danske Bank reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Danske Bank sold 25,464 Veracyte shares in Q4 2025, an estimated $874K.
  • Danske Bank first reported a position in Veracyte in Q3 2024 and held it in 5 quarters.
  • Danske Bank's Veracyte position peaked at $1.3M in Q4 2024.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Danske Bank's 13F filing for Q4 2025, filed 2 Feb 2026.